Carisma Therapeutics Inc. Accounts Payable
Carisma Therapeutics Inc. had Accounts Payable of $5.57 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-12
- 2025-09-30: Accounts Payable, Current $5.57M.
- 2025-06-30: Accounts Payable, Current $4.76M.
- 2025-03-31: Accounts Payable, Current $3.25M.
- 2024-12-31: Accounts Payable, Current $2.08M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $5.57M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $4.76M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.25M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.08M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $1.73M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.03M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.17M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.93M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.41M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.49M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.61M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.73M 10-K · filed 2024-04-01 | $1.23M 10-K · filed 2023-02-28 |
| 2022-09-30 | $514.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $1.67M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $666.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $2.85M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $3.91M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.23M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $2.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.10M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.52M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.27M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.07M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.90M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $2.58M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.18M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.68M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.37M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $1.39M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.31M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.39M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $907.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $1.37M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $1.25M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.21M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.67M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $1.76M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.85M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $1.59M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.25M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $2.28M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.88M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $2.04M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $2.46M 10-K · filed 2016-03-25 | |
| 2014-09-30 | $2.59M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $2.60M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $3.07M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.75M 10-K · filed 2015-03-06 |